Patten Group, Inc. Eli Lilly & CO Transaction History

Patten Group, Inc.

$440 Million
Q3 2024

A detailed history of Patten Group, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Patten Group, Inc. holds 2,960 shares of LLY stock, worth $2.35 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

2,960

Previous 3,025 2.15%

Holding current value

$2.35 Million

Previous $2.74 Million 4.24%

% of portfolio

0.6%

Previous 0.66%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$772.14 - $960.02 $50,189 - $62,401	-65 Reduced 2.15%	2,960 $2.62 Million
Q2 2024 Jul 25, 2024	BUY	$724.87 - $909.04 $117,428 - $147,264	162 Added 5.66%	3,025 $2.74 Million
Q1 2024 Apr 17, 2024	SELL	$592.2 - $792.28 $4,737 - $6,338	-8 Reduced 0.28%	2,863 $2.23 Million
Q4 2023 Jan 10, 2024	SELL	$525.19 - $619.13 $38,864 - $45,815	-74 Reduced 2.51%	2,871 $1.67 Million
Q3 2023 Oct 12, 2023	SELL	$434.7 - $599.3 $34,341 - $47,344	-79 Reduced 2.61%	2,945 $1.58 Million
Q2 2023 Jul 26, 2023	SELL	$350.74 - $468.98 $4,559 - $6,096	-13 Reduced 0.43%	3,024 $1.42 Million
Q1 2023 Apr 06, 2023	BUY	$310.63 - $364.82 $310 - $364	1 Added 0.03%	3,037 $1.04 Million
Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $5,144 - $5,994	-16 Reduced 0.52%	3,036 $1.11 Million
Q3 2022 Oct 13, 2022	BUY	$296.48 - $337.87 $46,843 - $53,383	158 Added 5.46%	3,052 $997,000
Q2 2022 Jul 18, 2022	SELL	$278.73 - $327.27 $9,198 - $10,799	-33 Reduced 1.13%	2,894 $949,000
Q1 2022 Apr 28, 2022	SELL	$234.69 - $291.66 $12,438 - $15,457	-53 Reduced 1.78%	2,927 $838,000
Q4 2021 Jan 20, 2022	BUY	$224.85 - $279.04 $28,555 - $35,438	127 Added 4.45%	2,980 $823,000
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $177,501 - $218,440	801 Added 39.04%	2,853 $659,000
Q2 2021 Aug 03, 2021	BUY	$180.55 - $233.54 $34,304 - $44,372	190 Added 10.2%	2,052 $471,000
Q1 2021 Apr 23, 2021	BUY	$164.32 - $212.72 $50,117 - $64,879	305 Added 19.59%	1,862 $348,000
Q2 2020 Jul 20, 2020	SELL	$136.42 - $164.18 $38,606 - $46,462	-283 Reduced 15.38%	1,557 $256,000
Q1 2020 Apr 16, 2020	BUY	$119.05 - $147.35 $28,572 - $35,364	240 Added 15.0%	1,840 $255,000
Q4 2019 Jan 14, 2020	BUY	$106.92 - $132.43 $171,072 - $211,888	1,600 New	1,600 $210,000
Q2 2019 Jul 11, 2019	SELL	$110.79 - $129.32 $188,343 - $219,844	-1,700 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$105.9 - $118.64 $21,180 - $23,728	200 Added 13.33%	1,700 $197,000
Q3 2017 Dec 13, 2017	BUY	$77.07 - $85.54 $106,587 - $118,301	1,383 Added 1182.05%	1,500 $128,000
Q3 2017 Nov 14, 2017	SELL	$77.07 - $85.54 $106,587 - $118,301	-1,383 Reduced 92.2%	117 $128,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,500	1,500 $123,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patten Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Patten Group, Inc. with notifications on news.

Account